Search Results for "New Arthritis Medication 2012"

23:53 EDT 21st August 2017 | BioPortfolio

Matching Channels

Matching News

Rheumatoid Arthritis Patients Shun Medical Advice

NHS Prescription Charges Stop Patients Receiving Life-Changing Medication  The National Rheumatoid Arthritis Society (NRAS) today releases four shocking statistics to highlight how the cost of an NHS...

Medication errors haven’t gone away

A 10-year analysis of medical malpractice cases indicates that medication errors continue to represent a significant risk to patients and health care providers, despite myriad efforts to eliminate tha...

Early intervention in pre-rheumatoid arthritis reduces risk of rheumatoid arthritis

Early therapeutic intervention in people with pre-rheumatoid arthritis significantly reduces the risk of the occurrence of rheumatoid arthritis 52 weeks later, experts highlight at the Annual European...

UK’s largest arthritis charities merge

Arthritis Care will merge into Arthritis Research UK and work as one charity from October 2017. Talks between the two organisations began at the start of the year, and after careful consideration it w...

A diagnosis of psoriatic arthritis led Pam Relph from the army to the Paralympics, just in time to win gold (twice)

Pam Relph’s heartbreak when she was medically discharged from the army due to psoriatic arthritis was rapidly followed by elation at finding herself on the British Paralympic rowing team, training f...

Psoriatic arthritis was associated with osteoporosis, ankylosing spondylitis

Investigators of this cross-sectional study found psoriasis and psoriatic arthritis correlated with pathologic fractures and other bone-related conditions. Johnathan I. Silverberg , MD...

Rheumatoid arthritis: What you should know

Arthritis is an umbrella term used to describe inflammation in the joints. Rheumatoid arthritis is a type of persistent arthritis that affects joints on both sides of the body, such as the hands, wris...

Lilly and Incyte Announce FDA Fails to Approve Baricitinib for Rheumatoid Arthritis

INDIANAPOLIS–(BUSINESS WIRE)–Eli Lilly and Company (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete re...

Matching PubMed Articles

Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions.

Self-injectable TNF inhibitors are increasingly used early in the chronic treatment of moderate to severe rheumatologic conditions. We estimated medication adherence/persistence over time following in...

Medication Non-Adherence in Systemic Lupus Erythematosus: A Systematic Review.

Medication non-adherence has not been well characterized in systemic lupus erythematosus (SLE). Our objective was to a conduct a systematic review of the literature examining the burden and determinan...

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.

To evaluate non-adherence to prescribed subcutaneous biologicals in rheumatoid arthritis (RA) patients in Spain.

Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.

AbbVie provides a free-to-patient patient support program (PSP) to assist adalimumab-treated patients with medication costs, nurse support, injection training, pen disposal, and medication reminders. ...

Effects of a Web-Based Patient Decision Aid on Biologic and Small Molecule Agents for Rheumatoid Arthritis, ANSWER-2: A Proof-of-Concept Study.

To assess the extent to which ANSWER-2, an interactive online patient decision aid, reduces patients' decisional conflict and improves their medication-related knowledge and self-management capacity.

Search Whole site using Google

Quick Search
Advertisement Advertisement